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Platypnea-orthodeoxia syndrome related to the patent foramen ovale and atrial 
septal aneurysm 
 
Sindrom platipneje-ortodeoksije, povezan s otvorenim foramenom ovale i aneurizmom 
interatrijskog septuma 
 





The platypnea-orthodeoxia syndrome is a rare condition characterized by postural dyspnea and hypoxemia 
that disappear or diminish in lying position, so it can be difficult to recognize without close assessment of the 
patient's pattern of dyspnea. The syndrome is commonly associated to an intra-cardiac right-to-left shunt 
through a patent foramen ovale as the most frequently reported site of the shunt. Platypnea-orthodeoxia 
syndrome can be the cause of refractory hypoxemia leading to pulmonary hypertension, whereby, if suspected, 
contrast echocardiography in supine as well as in upright position should be performed. We are presenting a 
case of an unrecognized platypnea-orthodeoxia syndrome because of a patent foramen ovale and atrial septal 
aneurysm, with developed chronic complications due to long-standing hypoxemia. This case highlights the 
need of a high index of suspicion to diagnose the syndrome on time and the necessity of careful 
echocardiographic evaluation. 





Sindrom platipneje-ortodeoksije je rijetko stanje koje je karakterizirano položajnom dispnejom i 
hipoksemijom koja nestaje ili se smanjuje u ležećem položaju, te ga je stoga teško dijagnosticirati ukoliko se 
pažljivo ne procijeni bolesnikov obrazac dispneje. Često je povezan s intrakardijalnim šantom i to kroz 
otvoreni foramen ovale, koji predstavlja najčešću lokaciju šanta. Sindrom platipneje-ortodeoksije može biti 
uzrokom refrakterne hipoksemije koja dovodi do plućne hipertenzije, pa je potrebno, ukoliko sumnjamo na 
ovaj sindrom, učiniti kontrastni ehokardiografski pregled, kako u ležećem, tako i u povišenom položaju 
bolesnika. U ovom prikazu slučaja predstaviti ćemo dugo neprepoznati sindrom platipneje-ortodeoksije koji 
je nastao kao posljedica otvorenog foramena ovale, uz prisutnu aneurizmu interatrijskog septuma i razvijene 
kronične komplikacije dugotrajne hipoksemije. Cilj ovoga prikaza je naglasiti kako je potrebna visoka razina 
sumnje i pomna ehokardiografska evaluacija da bismo na vrijeme prepoznali i dijagnosticirali ovaj sindrom. 
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The platypnea-orthodeoxia syndrome (POS) is 
characterized by postural dyspnea (platypnea) and 
hypoxemia (orthodeoxia) which disappear or diminish 
in a lying position. It is defined as PaO2 decline ≥ 5% 
or 4 mmHg when upright.1,2 The syndrome can         
occur with various intra-cardiac or extra-cardiac 
abnormalities, but the exact pathophysiological 
mechanism underlying this entity has not yet been 
defined. The most common etiologic association is an 
intra-cardiac right-to-left shunt through a patent 
foramen ovale (PFO), an atrial septal defect (ASD) or 
an atrial septal aneurysm (ASA).3 A small number of 
cases of POS have been reported so far, especially 
dealing with its complications. We present a case of an 
unrecognized POS because of a PFO and ASA, with 
developed chronic complications, as severe pulmonary 





A 67-year-old male patient was hospitalized due to 
progression of dyspnea and hoarseness. Several years 
earlier, the patient became dyspneic and noted that his 
lips and tongue turned blue. He was diagnosed with 
COPD with partial respiratory insufficiency two years 
before admission in another institution and was 
discharged with a long-term oxygen therapy with the 
flow of 8 L per minute. One year prior to admission, 
on routine transthoracic echocardiography (TTE) in 
another hospital, elevated systolic pressure in the right 
ventricle was recorded (40 mmHg) but no anatomical 
defect was described. He also had arterial hypertension 
for many years and stable coronary artery disease.  
At the moment of admission, he was dyspnoeic at 
rest, plethoric and centrally cyanotic with heart rate of 
100 min-1 and a blood pressure of 140/90 mmHg. We 
suspected that the possible causes of deterioration were 
as follows: acute COPD exacerbation, pneumonia 
(possibly interstitial), pulmonary embolism or heart 
failure. Oxygen was immediately delivered via a mask 
with a reservoir bag with the flow of 15 L per minute. 
Despite the treatment, his blood oxygen saturation was 
not satisfying (85-88%) without CO2 retention. We 
started with diagnostic workup to reach the final 
diagnosis, and, meanwhile, with standardized COPD 
exacerbation supportive treatment (intravenous 
glucocorticoids, inhaled bronchodilators, empirical 
parenteral antibiotic therapy). 
Laboratory findings showed polyglobulia 
(hemoglobin 182 g/L, hematocrit 0.527) with slightly 
elevated markers of inflammation. A chest X-ray 
revealed mild congestive changes in the basal parts of 




Figure 1 Chest X-ray 
Slika 1. Rendgenska snimka srca i pluća 
 
Electrocardiography showed normal sinus rhythm 
without signs of ischemia. Spirometry revealed 
obstructive airflow limitation of mild degree (forced 
vital capacity (FVC) 2.69 L, 69.7% predicted; forced 
expiratory volume in one second (FEV1) 1.79 L, 59.7% 
predicted; FEV1/FVC, 0.66) with a negative 
bronchodilator (salbutamol) test. Diffusing capacity of 
the lungs for CO (DLCO) was very low at the level of 
alveocapillar membrane (DLCO, 15.1%; transfer 
coefficient (KCO), 17.5% predicted; alveolar volume 
(VA), 88.5% predicted). The patient underwent MSCT 
pulmonary angiography and perfusion scintigraphy           
to exclude pulmonary embolism. The HRCT scan            
also excluded interstitial pathology. Since 
lymphadenopathy of the right cervical lymph nodes 
was noticed during clinical examination, needle  
biopsy for cytology was also done revealing metastatic 
planocellular cell carcinoma of the larynx. Further-
more, bronchoscopy was performed after a week and 
revealed a supraglottic arc formation in the ventricular 
folds which did not significantly narrow the airway. 
Bronchial anatomy was normal with no endobronchial 
lesions. Surprisingly, larvae of Strongyloides 
stercoralis were isolated in bronchial aspirate and, 
immediately after the isolation, albendazole was 
introduced followed by ivermectin. Glucocorticoids 
were withdrawn due to Strongyloides infection 
according to current literature.4 Despite the treatment 
attempts, no dyspnea amelioration occurred. 
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During the clinical rounds, we noticed a regression 
of cyanosis in a horizontal position which prompted us 
to suspect about POS. Consequently, blood gas 
analysis in both lying and sitting position was 
performed. In lying position, in room air, the patient 
had partial respiratory failure with respiratory alkalosis 
– PaO2 38 mmHg, PaCO2 33 mm Hg, pH 7.49, 
bicarbonates 25, BE + 3, SaO2 78%, while in a sitting 
position – PO2 34 mmHg, PaCO2 32 mm Hg, pH 7.49, 
bicarbonates 24, BE + 2, SaO2 72%. With oxygen 
therapy, saturation increased by 11% in lying position, 
while in sitting position it increased only by 2%. The 
criteria for POS were fulfilled so we proceeded with 
further investigations to identify its underlying 
mechanism. On TTE left ventricle ejection fraction 
was normal but the right atrium and ventricle were 
markedly dilated with paradoxical movements of 
interventricular septum due to the pressure overload of 
the right ventricle (Figure 2). Moderate tricuspid valve 
regurgitation was found with systolic pressure in the 
pulmonary artery of 80 mmHg. To evaluate for 
interatrial shunts, saline contrast study (bubble study) 
was done. It revealed no shunt while lying down, but 
in a sitting position it confirmed the presence of 
contrast in the left ventricle within three heartbeats 
which was indicative for an intra-cardiac shunt. In 
order to be able to directly visualize the cardiac         
defect, transoesophageal contrast ultrasound both in 
recumbent and elevated position was done and it 
ultimately demonstrated wide-open PFO with ASA 
(Figure 3). Right heart catheterization revealed 
precapillary pulmonary hypertension: SaO2 of 48% in 
the right atrium, 45% in the superior caval vein, and 
47% in the inferior caval vein, pulmonary capillary 
wedge pressure 12 mmHg, pulmonary artery pressure 
88/60/40 mmHg, right ventricle pressure 89/9 mmHg, 
right atrium pressure 10 mmHg and pulmonary 
vascular resistance 12 Wood units. We were not able 
to pass through PFO so the blood from the lung veins 
was not taken for analysis. After the demonstration of 
severe pulmonary hypertension, we presumed that the 
most likely cause of the condition was long-standing 
hypoxemia due to right-to-left shunting through the 
PFO with malformed interatrial septum in the form of 
ASA. 
The hospital team decided to deal with active 
malignant neoplasm (planocellular larynx cancer), and 
after achieving a stable stage, to introduce pulmonary 
hypertension therapy. As anesthesiologists suggested 
that general anesthesia for surgery was too risky, the 
oncology team indicated radiotherapy, but laryngeal 
stoma was necessary for this. The same day, a few 
hours after the procedure, the patient entered into 
respiratory arrest and was shortly reanimated and 
placed on mechanical ventilation, on which he spent 




Figure 2 Transthoracic echocardiography showing markedly dilated right heart chambers and a bubble study 
Slika 2. Transtorakalni ultrazvuk srca uz prikaz uvećanih desnostranih srčanih šupljina i kontrastna 
ehokardiografija 





Figure 3 Transoesophageal ultrasound in an elevated position demonstrating patent foramen ovale 





POS is an uncommon entity that can occur in a 
variety of clinical settings primarily caused by cardiac, 
pulmonary or hepatic diseases. It can be difficult to 
recognize without closely assessment of the patient's 
pattern of dyspnea.5,6 Various theories have been 
proposed to explain this condition, and they are 
discussed in the following text. 
The most common cause of POS is the intracardiac 
right-to-left shunt, present as PFO or, less commonly, 
as ASD and ASA.3,6-11 The condition becomes usually 
manifested after anatomic changes due to surgeries 
(pneumonectomy and lobectomy), or associated with 
kyphoscoliosis, aortic elongation and aneurysm.12-19 
According to literature, there are also some other 
conditions related to POS in the presence of PFO: 
eosinophilic endomyocardial disease, hypovolemia, 
pericardial diseases, compression of the right heart by 
a hydatid cyst of the liver, hemidiaphragm paralysis, 
blunt chest wall trauma.6,20-26 In most cases, the 
pulmonary artery pressure remains normal.16,17 
Cyanosis without pulmonary arterial hypertension 
should alert the possibility of an atrial right-to-left 
shunt, and considering the high frequency of PFO 
(according to autopsy studies the prevalence is 27%) 
as well as pulmonary surgeries performed nowadays, 
it could be possible that POS is underdiagnosed.27 Why 
do the symptoms occur considering the absence of a 
pressure gradient between the right and left atrium 
(either in the sitting or supine position) and the 
interatrial septum normally being functionally closed 
even in the presence of PFO? The possible explanation 
could be that orthodeoxia is generated from the stream 
of venous return being directed across the PFO, caused 
by mechanical deformation of the interatrial septum. 
Moreover, atrial emptying can be affected by changing 
the relationship of ventricular compliance in     
different pathologies (e.g. pneumonectomy or 
myocardial infarction) causing decrease in right 
ventricle compliance.6,8,11,27,28 It seems that an 
anatomic substrate like interatrial communication must 
coexist with a functional component that produces 
distortion in the interatrial septum thus resulting in 
preferential redirection of shunt flow in upright 
position through the interatrial defect even in the 
absence of a pressure gradient.29 Nevertheless, why the 
right-to left shunt occurs only in raised positions is not 
completely understood. 
On the other hand, the mechanism of intra-
pulmonary shunts in patients with chronic pulmonary 
disorders was explained by Altman and Robin on the 
basis of changes in the alveolar perfusion gradient.5 In 
the healthy lung, the blood flow is greater at the bases, 
while the alveolar pressure remains constant through 
the lung. The latter become substantially elevated as a 
result of alterations of ventilatory mechanics in 
different lung diseases. This is apparent in apical 
segments and intensified with upright positions. 
Finally, this can result in a decrease in pulmonary 
artery pressure and pulmonary capillary compression 
with respiratory dead space. The supine position 
virtually eliminates zone 1 (upper part of the lung) 
placing more of the lung in zone 3 (at the bases of the 
lung) so severe hypoxemia can occur when many gas 
exchange units are still perfused but not ventilated. 
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When the patient is in supine position, it is possible that 
the entire underperfused zone 1 converts into zone 3 
leading to equal perfusion and ventilation, ultimately 
sufficient oxygenation and whenever the patient 
becomes erect, increased perfusion of poorly 
ventilated zone 3 causes ventilation perfusion 
mismatch leading to platypnoea-orthodeoxia.  
In addition to intracardiac causes of POS, there are 
reports of POS occurring in various extracardiac 
disorders, mainly pulmonary. Hypoxic vascular 
pulmonary constriction may be inappropriate in COPD 
patients thus causing ventilation perfusion mismatch, 
and subsequently POS.30 Platypnea occurred in one 
COPD patient during ileus and disappeared after ileus 
had been resolved. It was suggested that impaired 
abdominal muscle contraction when upright was 
responsible for the development of platypnea.31 In 
another COPD patient, the cause of POS was found to 
be multiple pulmonary emboli with condition being 
improved on anticoagulation therapy.6 Massive 
pulmonary embolism with significant ventilation 
perfusion mismatch was the cause of POS in the case 
presented by Khokhar et al.32 POS was described 
during adult respiratory distress syndrome, crypto-
genic fibrosing alveolitis and in a patient with organo-
phosphorus poisoning on mechanical ventilation.33-35 
Continuous positive airway pressure treatment reduced 
orthodeoxia in the latter.34 Tumors of the upper 
airways can produce platypnea because of positional 
compression of airways or vascular structures (not the 
case with our patient).36 Platypnea has been described 
in a patient with postirradiation bronchitis which led to 
severe bronchial stenosis that was relieved by stent 
placement.37 There are reports of the association of 
platypnea with autonomic dysfunction causing an 
orthostatic increase in ventilation perfusion mismatch 
and showing improvement with fluid challenge.6,38,39 
POS can happen in relationship to the hepato-
pulmonary syndrome (HPS). It is estimated that 15% 
to 45% of patients with liver cirrhosis are hypoxemic 
without manifest heart or lung disease.40 HPS is a triad 
of hypoxemia, liver disease and intrapulmonary 
vascular dilatations.41 It may be transient as described 
in the case of an acute hepatitis A.42 Rodriguez-Roisin 
et al.43 have proposed four diagnostic criteria for the 
HPS: absence of cardiopulmonary disease, presence of 
chronic hepatic disease, pulmonary gas exchange 
abnormalities and intrapulmonary shunts. There may 
be other features that are not always present: shortness 
of breath with or without orthodeoxia and platypnea, 
low diffusing capacity, reduced pulmonary vascular 
pressures and increased cardiac output. Hypoxemia in 
HPS has various causes: diaphragmatic dysfunction, 
pleural effusions, impaired hypoxic vasoconstriction, 
precapillary and capillary intrapulmonary vascular 
dilatations resulting in shunts and impaired matching 
of ventilation to perfusion.44 When the patient is raised, 
because of gravity, the blood is redirected to the dilated 
precapillary beds of the lower lung parts thus 
increasing the arteriovenous shunting and resulting in 
orthostatic hypoxemia.8 
Consequently, POS should be considered in the 
differential diagnosis of unexplained dyspnea and 
refractory hypoxemia. Demonstration of platypnea and 
blood gas analysis in supine and upright positions are 
the initial assessments to confirm orthostatic 
desaturation. Then, the next step is identification of the 
underlying mechanism of POS. A definitive diagnosis 
can be made in most cases by contrast-enhanced 
echocardiography (bubble study) with postural 
manoeuvers (bed tilt).45 Contrast tilt-table transo-
esophageal echocardiography (TOE) is the most 
sensitive test for the noninvasive diagnosis of a right-
to-left shunt and should be performed with the patient 
both supine and upright.46 Intrapulmonary shunts 
should be considered if an intracardiac shunt is not 
detected. The presence of intrapulmonary vascular 
dilatations can be shown by: 99mTc-labeled macro-
aggregated albumin scanning, contrast-enhanced 
echocardiography, pulmonary arteriography. Once 
again, contrast-enhanced echocardiography is the 
method of choice but the passage of contrast through 
the dilated pulmonary vessels to the left atrium shows 
a delay of 3-6 heart beats. Angiography is reserved for 
patients with poor response to therapy and defines 
whether embolization could be performed.8,47,48 
The treatment of POS depends on the cause. 
Closure of the defect is the treatment of choice for 
intracardiac (usually interatrial) communication 
without pulmonary hypertension. It can be performed 
surgically or by transcatheter techniques with different 
devices.6,8,10,13,16,49-51 The treatment of the underlying 
pulmonary condition leads to a better ventilation 
perfusion matching.8 No definitive medical treatment 
has been effective in improving symptoms in HPS 
except in an anecdotal case with antimicrobial agents 
in cirrhosis since they can reduce endotoxemia                 
and nitric oxid production which is a potent 
vasodilator.44,52,53 Approximately 80% of patients with 
HPS improved oxygenation after liver transplantation 
but hypoxemia carries a high perioperative mortality.47 
Intrahepatic portosystemic shunt can be also 
considered for patients with HPS.54 
Our patient’s initial symptoms were connected to 
severe hypoxia without right heart remodeling and 
significant pulmonary hypertension. Hypoxia that does 
not improve on oxygen could not be only due to COPD 
(especially when only moderate obstructive ventilation 
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disorders are present and there is no CO2 retention as 
in our patient), but it is often caused by a shunt, either 
intracardial or intrapulmonary, which in turn causes 
pulmonary hypertension. It was not possible to detect 
the shunt only performing standard TTE without 
position manoeuvers so the defect remained 
unrecognized. Desaturation in the upright position was 
primarily caused by anatomic opening of the foramen 
ovale and probably enhanced by ASA which resulted 
in the redirection of shunt flow across a malformed 
septum when upright. Desaturation later, increased by 
development of secondary pulmonary hypertension, 
led to a vicious circle. On the other hand, with simple 
primary or secondary pulmonary exactly the opposite 
hypertension would be expected to happen – the load 
of the right heart would be reduced by erection and 
thus the shunt. POS is a relatively rare cause of 
dyspnea and cyanosis and it is often not considered by 
physicians. It is essential to have a high index of 
suspicion to diagnose POS, and if suspected, contrast 
echocardiography should be done in supine as well as 
in upright position, ideally with TOE. Unfortunately, 
the condition in our patient was diagnosed too late and 
in an advanced stage in which the patient could not 




ASA – atrial septal aneurysm  
ASD – atrial septal defect  
BE – base excess 
COPD – chronic obstructive pulmonary disease 
DLCO – diffusing capacity 
FEV1– forced expiratory volume in first second 
FEV1/FVC – Tiffeneau-Pinelli index 
FVC – forced vital capacity 
HPS – hepatopulmonary syndrome 
HRCT – high–resolution computed tomography 
KCO – carbon monoxide transfer coefficient 
L – liter 
MSCT – multi-slice computed tomography  
pH – potential of hydrogen 
PaCO2 – partial pressure of carbon dioxide 
PaO2 – arterial partial pressure of oxygen 
PFO – patent foramen ovale 
POS – platypnea-orthodeoxia syndrome 
SaO2 – oxygen saturation 
TOE – transoesophageal echocardiography  
TTE – transthoracic echocardiography 
VA – alveolar volume 
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